Is there a relationship between part D medication adherence and part C intermediate outcomes star ratings measures?

Journal of Managed Care and Specialty Pharmacy

Volumn 22, Issue 7, 2016, Pages 787-795

  Ta, Jamie T ^a,b   Erickson, Sara C ^b   Qiu, Wenyi Amanda ^b   Patel, Bimal V ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b MedImpact Healthcare Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRESCRIPTION DRUG;

ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; MEDICARE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; ADOLESCENT; ADULT; AGED; ECONOMICS; EPIDEMIOLOGY; EVALUATION STUDY; FEMALE; MALE; MIDDLE AGED; STANDARDS; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICARE PART C; MEDICARE PART D; MEDICATION ADHERENCE; MIDDLE AGED; PRESCRIPTION DRUGS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84976904206     PISSN: 23760540     EISSN: 23761032     Source Type: Journal    
DOI: 10.18553/jmcp.2016.22.7.787     Document Type: Article

References (32)

1. Academy of Managed Care Pharmacy, American Pharmacists Association. Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality. J Am Pharm Assoc (2003). 2014;54(3):228-40. Available at: http://www.japha.org/article/S1544-3191(15)30180-1/fulltext#s0090. Accessed June 1, 2016.
2. Centers for Medicare & Medicaid Services. Medicare 2015 Part C & D star rating technical notes. In: 2015 Part C & D Medicare star ratings data (v4 16 2015). Available at: http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/PerformanceData.html. Accessed June 1, 2016.
3. Jacobson G, Neuman T, Damico A, Huang J. Medicare Advantage plan star ratings and bonus payments in 2012. Data Brief. Kaiser Family Foundation. November 2011. Available at: http://kaiserfamilyfoundation.files.wordpress. com/2013/01/8257.pdf. Accessed June 1, 2016.
4. Centers for Medicare & Medicaid Services. Advance notice of methodological changes for calendar year (CY) 2015 for Medicare Advantage (MA) capitation rates, Part C and Part D payment policies and 2015 call letter. February 21, 2014. Available at: https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/downloads/Advance2015.pdf. Accessed June 1, 2016.
5. Reid RO, Deb P, Howell BL, Shrank WH. Association between Medicare Advantage plan star ratings and enrollment. JAMA. 2013;309(3):267-74. Available at: http://jama.jamanetwork.com/article.aspx?articleid=1557733. Accessed June 1, 2016.
6. Jacobson G, Damico A, Neuman T, Gold M. Medicare Advantage 2015 spotlight: enrollment market update. Issue Brief. Kaiser Family Foundation. June 30, 2015. Available at: http://kff.org/medicare/issue-brief/medicareadvantage-2015-spotlight-enrollment-market-update/. Accessed June 1, 2016.
7. Centers for Medicare & Medicaid Services. Announcement of calendar year (CY) 2016 Medicare Advantage capitation rates and Medicare Advantage and Part D payment policies and final call letter. April 6, 2015. Available at:https://www.cms.gov/medicare/health-plans/medicareadvtgspecratestats/downloads/announcement2016.pdf. Accessed June 1, 2016.
8. Centers for Medicare & Medicaid Services. Part C and D performance data. Available at: https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovgenin/performancedata.html. Accessed June 1, 2016.
9. URAC. Pharmacy benefit management measures. Measures at a glance. February 26, 2015. Updated March 28, 2016. Available at: https://www. urac.org/wp-content/uploads/PBM_Measures_AtAGlance:02-26-2015.pdf. Accessed June 1, 2016.
10. Centers for Medicare & Medicaid Services. Quality rating system measure technical specifications. September 2015. Available at: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityInitiativesGenInfo/Downloads/2016-QRS-Measure-Technical-Specifications.pdf. Accessed June 6, 2016.
11. Shalev V, Goldshtein I, Halpern Y, Chodick G. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings. Pharmacotherapy. 2014;34(1):1-8.
12. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12(3):239-45. Available at: http://amcp.org/data/jmcp/Research_239-245.pdf.
13. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-41. Available at: http://archinte.jamanetwork. com/article.aspx?articleid=410956. Accessed June 1, 2016.
14. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care. 2008;14(2):71-75. Available at: http://www.ajmc.com/journals/issue/2008/2008-02-vol14-n2/Feb08-2832p071-075/. Accessed June 1, 2016.
15. Schmittdiel J, Raebel M, Dyer W, et al. Medicare star excludes diabetes patients with poor CVD risk factor control. Am J Manag Care. 2014;20(12):e573-81. Available at: http://www.ajmc.com/journals/issue/2014/2014- vol20-n12/Medicare-Star-Excludes-Diabetes-Patients-With-Poor-CVD-Risk-Factor-Control/. Accessed June 1, 2016.
16. Holman RR, Thorne KI, Farmer AJ, et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med. 2007;357(17):1716-30. Available at: http://www.nejm.org/doi/full/10.1056/NEJMoa075392#t=articleTop. Accessed June 1, 2016.
17. Davis KL, Tangirala M, Meyers JL, Wei W. Real-world comparative outcomes of U.S. type 2 diabetes patients initiating analog basal insulin therapy. Curr Med Res Opin. 2013;29(9):1083-91.
18. Donnelly LA, Morris AD, Evans JM; DARTS/MEMO collaboration. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM. 2007;100(6):345-50. Available at: http://qjmed. oxfordjournals.org/content/100/6/345.long. Accessed June 1, 2016.
19. Eby EL, Van Brunt K, Brusko C, Curtis B, Lage MJ. Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes. Clin Interv Aging. 2015;10:991-1001. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476426/. Accessed June 1, 2016.
20. Lee LJ, Li Q, Reynolds MW, Pawaskar MD, Corrigan SM. Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe. J Med Econ. 2011;14(1):75-86.
21. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension:the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126(17):2105-14. Available at: http://circ.ahajournals. org/content/126/17/2105.long. Accessed June 1, 2016.
22. Stafford RS, Monti V, Furberg CD, Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension. 2006;48(2):213-18. Available at: http://hyper. ahajournals.org/content/48/2/213.long. Accessed June 1, 2016.
23. Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. Circulation. 2006;113(2):213-21. Available at: http://circ.ahajournals.org/content/113/2/213.long. Accessed June 1, 2016.
24. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. Available at: http://jama.jamanetwork.com/article. aspx?articleid=1791497. Accessed June 1, 2016.
25. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-934. Available at: http://content.onlinejacc.org/article. aspx?articleid=1879710. Accessed June 1, 2016.
26. Centers for Medicare & Medicaid Services. Examining the potential effects of socioeconomic factors on star ratings. September 8, 2015. Available at: http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/Research-on-the-Impact-of-Socioeconomic-Status-on-Star-Ratingsv1-09082015.pdf. Accessed June 1, 2016.
27. Xu P, Burgess JF Jr, Cabral H, Soria-Saucedo R, Kazis LE. Relationships between Medicare Advantage contract characteristics and quality-of-care ratings: an observational analysis of Medicare Advantage star ratings. Ann Intern Med. 2015;162(5):353-58.
28. Leslie RS, Tirado B, Patel BV, Rein PJ. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures. J Manag Care Spec Pharm. 2014;20(12):1193-203. Available at: http://www. jmcp.org/doi/abs/10.18553/jmcp.2014.20.12.1193.
29. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563-71. Available at: http://jama.jamanetwork.com/article.aspx?articleid=204402. Accessed June 1, 2016.
30. Spence MM, Makarem AF, Reyes SL, et al. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease. J Manag Care Spec Pharm. 2014;20(10):1036-45. Available at: http://www.jmcp.org/doi/abs/10.18553/jmcp.2014.20.10.1036.
31. Seabury SA, Lakdawalla DN, Dougherty JS, Sullivan J, Goldman DP. Medication adherence and measures of health plan quality. Am J Manag Care. 2015;21(6):e379-89. Available at: http://www.ajmc.com/journals/issue/2015/2015-vol21-n6/Medication-Adherence-and-Measures-of-Health-Plan-Quality/. Accessed June 1, 2016.
32. Centers for Medicare & Medicaid Services. Medicare 2016 Part C & D star rating technical notes. In: 2016 Part C & D Medicare Star Ratings Data (v04 07 2016). Available at: https://www.cms.gov/medicare/prescriptiondrug- coverage/prescriptiondrugcovgenin/performancedata.html. Accessed June 6, 2016.